A

Aquestive Therapeutics
D

AQST

4.15000
USD
-0.46
(-9.98%)
مفتوح الان
آخر تحديث: · متأخرة 15 دقيقة
حجم التداول
126,975
الربح لكل سهم
-0
العائد الربحي
-
P/E
-6
حجم السوق
520,245,781
أصول ذات صلة

العنوان: Aquestive Therapeutics

القطاع: الرعاية الصحية
الصناعة: Drug Manufacturers - Specialty & Generic
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.